SEATTLE, March 18, 2021, (MEDGADGET) — Global Near-patient Molecular Solution Market – Insights
Near-patient molecular solution aids in convenient diagnose and health monitoring. The approach is also called as point-of-care diagnosis. Basic health monitoring smartphone apps, wearable devices, and biosensors are some of the technologies used in patient health monitoring. Near-patient molecular solutions offer easy-to-access testing solutions that offer accurate results in lesser time compared to conventional lab-based tests.
Request Sample Copy of the Business Report: https://www.coherentmarketinsights.com/insight/request-sample/47
Global Near-patient Molecular Solution Market: Drivers
High prevalence of cardiovascular diseases and diabetes is expected to propel growth of the global near-patient molecular solution market over the forecast period. For instance, according to the Institute for Health Metrics and Evaluation (IHME), the number of deaths due to cardiovascular diseases worldwide increased by 41% between 1990 and 2013, from 12.3 million to 17.3 million deaths. Moreover, South Asia experienced the largest increase in total deaths, with 1.8 million more deaths in 2013 than in 1990—an alarming increase of 97%. Moreover, increasing demand for home-based point-of-care devices is also expected to fuel growth of the market. Such scenario has also prompted manufacturers to develop technologies that offer quick and accurate results.
Global Near-patient Molecular Solution Market: Restraints
Lack of trained professionals is expected to hinder growth of the global near-patient molecular solution market to a certain extent.
Global Near-patient Molecular Solution Market Taxonomy
On the basis of technology, the global near-patient molecular solution market is segmented into:
- Genetic Sequencing-based
On the basis of application, the global near-patient molecular solution market is segmented into:
- Infectious diseases testing kits
- Human Immunodeficiency Virus (HIV)
- Pregnancy and fertility kits
- Hematology testing kits
- Urinalysis testing kits
- Glucose monitoring kits
On the basis of end-user, the global near-patient molecular solution market is segmented into:
- Research Laboratories
- Diagnostic Laboratories
On the basis of region, the global near-patient molecular solution market is segmented into:
- North America
- Latin America
- Asia Pacific
- Middle East
Exclusive offer!!! Purchase the report at a discounted rate!!!
Apply Promo Code “CMIFIRST1000” and Get Up to 30% Discount
Quick Buy – Near Patient Molecular Solution Market Research Report: https://bit.ly/3rYAjBS
PCR-based: Idylla is a real-time PCR-based molecular diagnostic system that offers rapid access to highly reliable clinical molecular diagnostic information and may lead to more personalized therapy.
Genetic Sequencing-based: It enables genetic sequencing and analysis of DNA data at point of care with high accuracy.
Hybridization-based: Peptide nucleic acid (PNA) molecular beacon probe is used to quantify 16SrRNA of specific populations in RNA extract of environmental samples.
Global Near-patient Molecular Solution Market: Regional Analysis
North America is expected to witness significant growth in the global near-patient molecular solution market during the forecast period. This is attributed to factors such as high incidence of infectious diseases, technological advancements in molecular diagnostic tools, and increasing patient awareness.
Asia Pacific is expected to witness rapid growth in the global near-patient molecular solution market, owing to increasing R&D activities and high prevalence of infectious diseases in the region. Moreover, increasing population and growing disposable income in developing countries such as India and China is also expected to aid in growth of the market.
Global Near-patient Molecular Solution Market: Competitive Landscape
Major players operating in the global near-patient molecular solution market include Abbott Laboratories, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., F. Hoffmann-La Roche Ltd, Siemens AG, Veridex, LLC, Luminex Corp., and GenMark Diagnostics.
To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/near-patient-molecular-solution-market-47
Global Near-patient Molecular Solution Market: Key Developments
Key players in the market are focused on adopting product approval and launch strategies to expand their product portfolio. For instance, in November 2016, Abbott received CE mark for its i-STAT Alinity handheld blood testing platform. Similarly, in May 2019, Siemens Healthineers, a subsidiary of Siemens AG, launched Atellica Solution at 23rd IFCC-EFLM European Congress of Clinical Chemistry and Laboratory Medicine held at Barcelona, Spain. Atelllica is designed to address common clinical laboratory challenges.
Key players in the market are also focused on adopting M&A strategies to expand their product portfolio. For instance, in November 2016, Siemens Healthineers acquired Conworx Technology to expand its point-of-care informatics capabilities.
Major players in the market are focused on gaining regulatory certification, in order to enhance their market presence. For instance, in December 2018, Becton, Dickinson and Company received the U.S. Food and Drug Administration 510(k) clearance for its BD MAX enteric viral panel, a molecular diagnostic test for direct qualitative detection and differentiation of enteric viral pathogens. Similarly, in June 2019, Becton, Dickinson, and Company announced CE-IVDD certification for BD COR System indicated for disease diagnostics, in Europe.
Table of Content
Global Near Patient Molecular Solution Market Research Report
Section 1: Global Near Patient Molecular Solution Industry Overview
Section 2: Global Economic Impact on Near Patient Molecular Solution Industry
Section 3: Global Market Competition by Industry Producers
Section 4: Global Productions, Revenue (Value), according to Regions
Section 5: Global Supplies (Production), Consumption, Export, Import, geographically
Section 6: Global Productions, Revenue (Value), Price Trend, Product Type
Section 7: Global Market Analysis, on the basis of Application
Section 8: Near Patient Molecular Solution Market Pricing Analysis
Section 9: Market Chain, Sourcing Strategy and Downstream Buyers
Section 10: Strategies and key policies by Distributors/Suppliers/Traders
Section 11: Key Marketing Strategy Analysis, by Market Vendors
Section 12: Market Effect Factors Analysis
Section 13: Global Near Patient Molecular Solution Market Forecast
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027